FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christine Millet

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Anatomy

Thyroid Gland

Procedures

Co-author Network

Publications

TOP 3
Jacques Irani; Laurent Salomon; Michel Soulié; Alexandre R Zlotta; Alexandre de la Taille; Bertrand Doré; Christine Millet
Urinary/serum prostate-specific antigen ratio: comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer detection.
Jacques Irani; F Desgrandchamps; Christine Millet; M E Toubert; D Bon; J Aubert; A Le Duc
BTA stat and BTA TRAK: A comparative evaluation of urine testing for the diagnosis of transitional cell carcinoma of the bladder.
Jacques Irani; Christine Millet; Pierre Levillain; Bertrand Doré; F Bégon; J Aubert
[Serum and urine prostate-specific antigen ratio: its value in the distinction between prostate cancer and adenoma when serum prostate-specific antigen level is between 4 and 10 ng/ml].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christine Millet (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Jacques Irani; Laurent Salomon; Michel Soulié; Alexandre R Zlotta; Alexandre de la Taille; Bertrand Doré; Christine Millet
Urinary/serum prostate-specific antigen ratio: comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer detection.
Urology 2005;65(3):533-7.
1999: Jacques Irani; F Desgrandchamps; Christine Millet; M E Toubert; D Bon; J Aubert; A Le Duc
BTA stat and BTA TRAK: A comparative evaluation of urine testing for the diagnosis of transitional cell carcinoma of the bladder.
European urology 1999;35(2):89-92.
1997: Jacques Irani; Christine Millet; Pierre Levillain; Bertrand Doré; F Bégon; J Aubert
[Serum and urine prostate-specific antigen ratio: its value in the distinction between prostate cancer and adenoma when serum prostate-specific antigen level is between 4 and 10 ng/ml].
Chirurgie; mémoires de l'Académie de chirurgie 1997;122(8-9):478-82.
1997: Jacques Irani; Christine Millet; Pierre Levillain; Bertrand Doré; F Begon; J Aubert
Serum-to-urinary prostate specific antigen ratio: its impact in distinguishing prostate cancer when serum prostate specific antigen level is 4 to 10 ng./ml.
The Journal of urology 1997;157(1):185-8.
1996: T Métayé; A Bareille Saint-Gaudens; Christine Millet; P Ingrand; A Daban; F Bégon
[Immunoenzymatic assays of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer: correlation with clinical and biological parameters].
Annales de biologie clinique 1996;54(3-4):131-8.
1996: Jacques Irani; Christine Millet; Pierre Levillain; Bertrand Doré; F Begon; J Aubert
Serum-to-urinary prostate-specific antigen ratio: a potential means of distinguishing benign prostatic hyperplasia from prostate cancer.
European urology 1996;29(4):407-12.
1995: Jean-Louis Kraimps; T Métayé; Christine Millet; D Margerit; P Ingrand; Jean-Michel Goujon; Pierre Levillain; P Babin; F Begon; Jacques Barbier
Cathepsin D in normal and neoplastic thyroid tissues.
Surgery 1995;118(6):1036-40.
1993: T Métayé; Christine Millet; Jean-Louis Kraimps; B Aubouin; Jacques Barbier; F Bégon
Estrogen receptors and cathepsin D in human thyroid tissue.
Cancer 1993;72(6):1991-6.
1992: T Metaye; Christine Millet; Jean-Louis Kraimps; B Saunier; Jacques Barbier; F Begon
Effect of bromolevamisole and other imidazo [2,1-b] thiazole derivatives on adenylate cyclase activity.
Biochemical pharmacology 1992;43(7):1507-11.